SeraNovo has officially filed its first patent with the assistance of Harrie Marsman of V.O. Patents and Trademarks.
Detailed in the patent is the method, developed by SeraNovo, to design a liquid formulation specifically for a single medicine. SeraNovo’s technology allows new medicines to be absorbed in the human body that previously could not. Over time this will create a new wave of medications in fields including Cancer, HIV and Arthritis.
This first patent forms the foundation of SeraNovo’s protection strategy and will be built upon in the near future. We look forward to a fruitful collaboration with V.O. in the coming years.